Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Health

The Society for Immunotherapy of Cancer and the International Bladder Cancer Group Publish Recommendations for Clinical Trial Design in Bladder Cancer

Leave a comment


“The SITC-IBCG Bladder Cancer Clinical Trial Design Expert Panel was formed as a collaborative effort between these two organizations to identify the optimal approach to designing trials that will capture the benefit of medical therapies for each unique stage of bladder cancer,” said Matthew D. Galsky, MD, Chair, SITC-IBCG Bladder Cancer Clinical Trial Design Expert Panel.

The Expert Panel was composed of leaders in the field of bladder cancer, including a patient advocate provided by the Bladder Cancer Advocacy Network (BCAN). The Expert Panel generated evidence- and consensus-based recommendations to help clinician scientists tailor trials specific to urothelial carcinoma stage (including low-risk non-muscle invasive bladder cancer through metastatic disease) and treatment approach (eg, trimodality therapy versus neoadjuvant or adjuvant therapy).

“The recommendations detailed in the SITC-IBCG Clinical Trial Designs in Bladder Cancer publication describe how to design trials that will generate comparable and robust data,” said Ashish M. Kamat, MD, MBBS, FACS, Chair of the SITC-IBCG Bladder Cancer Clinical Trial Design Expert Panel. “These data will ultimately lead to higher rates of bladder function preservation and prevention of progression or recurrence for patients with localized disease, and improved quality and length of life for patients with metastatic disease.”

A significant unmet need exists for new UC treatments, and standardized trials designed with high-yield endpoints are critical for identifying therapies that will have the most positive impact for patients. The SITC-IBCG Clinical Trial Designs in Bladder Cancer paper includes recommendations for study design, including enrollment criteria, study objectives, endpoints, response measurement, statistics (including minimal value for effect and sample size considerations), and pathology considerations. These study design elements are summarized according to disease stage and treatment modality for comparison in the paper’s table.

For interested clinicians, SITC will host a live, free webinar focusing on the manuscript content, including a question-and-answer session with the authors. More information on the publication as well as the upcoming webinar can be found here: https://www.sitcancer.org/professional-development/clinical-trials-training-resources/bladder-cancer-trial-design.

About SITC
Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, health care professionals, government leaders and industry professionals around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Learn more about SITC, our educational offerings and other resources at sitcancer.org and follow us on X, LinkedIn and YouTube.

About IBCG
The International Bladder Cancer Group (IBCG) is a globally recognized entity that has published numerous peer-reviewed articles addressing knowledge gaps in – and providing recommendations for – the management of bladder cancer.

The IBCG was formed with a primary objective being to address global educational needs and learning gaps in order to improve the care and management of patients with urothelial carcinoma. The inaugural meeting, in 2006, consisted of members selected as representatives of their varied geographic regions across Europe, North America and Asia. The members were specifically selected not only for their expertise but also to ensure representation from across the globe.

Over the years, the mission of the IBCG has been to improve outcomes of patients suffering from bladder cancer through critical evaluation and leveraging of existing data to drive evidence-based treatment. An additional goal is to develop practical educational tools that are applicable to the global urological community and thus enhance the care of patients with bladder cancer on a global level.

You can read more about IBCG at https://www.ibcg.info/.

Media Contact
Thomas Martin, Society for Immunotherapy of Cancer, 414-271-2456, [email protected], www.sitcancer.org

Twitter

SOURCE Society for Immunotherapy of Cancer



Health

The Journey Venture Studio Announces Partnership With The NARBHA Institute

Leave a comment


The support of NARBHA will enable The Journey to continue its mission of providing resources to underrepresented founders, giving them a foundation to succeed in developing future disruptive healthcare startups. This partnership will play a pivotal role in providing women and minority founders access to leading healthcare organizations in the state with the opportunity to tap in to on the ground expertise and test and validate innovative ideas and concepts.

“The best startups are those that solve real problems and there is no one that understands the unique challenges in healthcare better than those providing access to it on the front lines,” said Mark Moeremans, managing director of The Journey. “We are excited to tap into the expertise of NARBHA and have access to one of the most impressive health organizations in the country. For a founder, this type of partnership is an entrepreneur’s dream, a potential sandbox to ideate, validate, pilot, and potentially sell into a reputable healthcare provider.”

The Journey’s commitment to closing the racial and gender gap in entrepreneurship aligns seamlessly with The NARBHA Institution’s mission to advance wellbeing in Northern Arizona by inspiring hope, energizing coalitions, and amplifying diverse voices. This collaboration signifies a shared dedication to making a meaningful difference and driving progress within the field of healthcare tech.

“We are honored to be able to partner with The Journey to enhance diverse voices that will create change within the healthcare industry,” said Mary Jo Gregory of NARBHA Institute. “We believe our influence to advance wellbeing is powered by investing in the next generation of people, technology, and science, augmented by embracing diversity and welcoming innovative discovery.”

The NARBHA Institute, originally founded to conduct community programs, research, treatment, and services in the mental health field, NARBHA became a managed care entity and served for several decades as a state-contracted Regional Behavioral Health Authority. In 2015, NARBHA developed a partnership with Health Choice Arizona, now a part of Blue Cross Blue Shield of Arizona, to implement the integration of physical and behavioral health and community reinvestment. Anchored on NARBHA’s legacy, The Institute shares its retained funds and broad resources to illuminate and strengthen health equity.

The Journey Venture Studio is a mission-driven venture studio building disruptive healthcare companies in partnership with the next generation of diverse founders. Its mission is to close the racial and gender opportunity gap by empowering diverse founders to pursue entrepreneurship while providing resources and support to increase their odds of success. For more information visit https://thejourneyventures.com.

The Journey Venture Studio
The Journey, a Phoenix-based 501c3 not-for-profit entity, is a venture studio creating and launching healthcare companies to be led by underrepresented founders. With a mission to launch healthcare companies aimed at improving health outcomes while creating opportunities for historically underrepresented entrepreneurs from around the country through a tailored venture fellowship, The Journey will activate a new generation of diverse founders; leveling the playing field and bringing world-changing healthcare solutions and technology to life.

Media Contact

Lisa Sass, Serendipit Consulting, 602.726.4080, [email protected], www.serendipitconsulting.com 

SOURCE The Journey Venture Studio

Health

American Entrepreneur with Kevin Harrington Launches Strategic Partnership with The Inle BrainFit Institute

Leave a comment


Kevin Harrington, one of the original Sharks from hit reality series Shark Tank, and his latest project, American Entrepreneur, have launched a strategic partnership with The Inle BrainFit Institute.

ST. PETERSBURG, Fla., Oct. 9, 2023 /PRNewswire-PRWeb/ — Founded by a board-certified neurologist, Dr. Philippe Douyon, The Inle BrainFit Institute is a neurology organization dedicated to overall health and wellness relating to the brain.

“For many years as a Neurologist, I found that the biggest impact I had on my patient’s lives was not when I prescribed them medication or took them to the operating room, it was when I got them to think differently about their health and their lives,” says Dr. Philippe Douyon, Founder of The Inle BrainFit Institute. “Helping people think differently and having a different relationship with their brains is the reason why so many of the people I’ve worked with have been able to transform their lives.”

“With a medical background and expertise in neuroscience, you can really trust Dr. Philippe Douyon and others at The Inle BrainFit Institute to help you improve your health, business, and life,” says Doug Scott, Executive Producer at American Entrepreneur. “If you’re ready to change any existing patterns of thinking and beliefs that may be holding you back, you’ve got to check out their online course, Take Charge of Your Brain. It teaches people how to become the leaders their brains need in order for them to overcome challenges, improve their health, create the businesses that they desire, and live happy and fulfilling lives.”

“My strategic partnership with American Entrepreneur and Kevin Harrington has opened new doors for business opportunities and connections, which I find very exciting,” says Dr. Philippe Douyon.

The Inle BrainFit Institute has been featured nationally on Fox Business Network with Kevin Harrington and has an upcoming feature in Forbes Magazine.

About American Entrepreneur

American Entrepreneur is the newest venture of business mogul and serial entrepreneur, Kevin Harrington. It’s a trusted information source for the latest trends, business stories, and product innovations. Harrington interviews the business leaders in a 3–5-minute video for their own use and records an individualized 15-30 second endorsement spot to air on national business news networks.

About Kevin Harrington

For more than 30 years, Kevin Harrington has empowered entrepreneurs and innovative business leaders to turn their dreams into a mind-boggling reality. As the creator of the infomercial and pioneer of the As Seen on TV brand, as well as an original Shark on the hit TV show Shark Tank, Kevin knows what it takes to be a successful entrepreneur. His legendary work behind-the-scenes of business ventures has produced well over $5 billion in global sales, the launch of more than 500 products, and the making of dozens of millionaires. Kevin’s been called “The Entrepreneur’s Entrepreneur” and the “Entrepreneur Answer Man,” because he knows the unique challenges start-ups have to face and has a special passion for helping entrepreneurs succeed.

For more information on The Inle BrainFit Institute, please visit www.InleBrainFitInstitute.com.

Media Contact

Scott Shields, Fortune Media Group, 1 754-755-9933 4363, [email protected], www.khentreprenuer.com

SOURCE Fortune Media Group

Health

Addressing the Risks of Nitrosamine Contamination in Pharmaceuticals, Upcoming Webinar Hosted by Xtalks

Leave a comment


Topics in this webinar will include:

  • Background on nitrosamines, including factors that increase the risk of contamination in pharmaceuticals
  • Recent scientific developments that have enhanced the requirements for risk assessment, testing and mitigation
  • Regulatory guidance on assessing the risk of — and identifying the root cause for — potential nitrosamine impurities
  • Reporting and notification requirements for nitrosamines in pharmaceuticals
  • Recent Food and Drug Administration (FDA) guidance on nitrosamine drug substance-related impurities (NDSRIs) and implementation requirements

Join this webinar to gain insights into nitrosamine contamination in drug manufacturing and the current scientific and regulatory landscape.

Join experts from Premier Consulting, Dr. Olu Aloba, Vice President, CMC Services; and Dr. Marianthi Karakatsani, Director, CMC Development Strategy, for the live webinar on Thursday, October 19, 2023, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit 2023 RAPS Article of The Year: Addressing the Risks of Nitrosamine Contamination in Pharmaceuticals.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]

SOURCE Xtalks

Health

Mass-directed Fraction Collection in High Performance Liquid Chromatography, Upcoming Webinar Hosted by Xtalks

Leave a comment


In this webinar, attendees will learn the basics of mass spectrometry and common mass spectrometry ionization techniques — electrospray ionization (ESI) and atmospheric pressure chemical ionization (APCI). They will also learn how mass spectrometry can increase efficiency and flexibility in developing chromatography workflows by allowing targeted purification and collection.

Join this webinar to gain insights on how mass spectrometry can supplement other detection methods such as UV detection in addition to being a viable alternative detection method.

Join experts from Gilson, Melanie Cathman, Test and Evaluation Manager; and Jordan Ho, PhD, Applications Specialist, for the live webinar on Monday, October 23, 2023, at 10am PDT (1pm EDT).

For more information, or to register for this event, visit Mass-directed Fraction Collection in High Performance Liquid Chromatography.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected] 

SOURCE Xtalks

Health

New Healthcare & Life Sciences Communications Firm, ReadHealthy Communications, Announces Company Launch

Leave a comment


“I learned so much and helped tell so many important stories in healthcare while working at other communications and PR agencies for the past decade,” said Jennifer Ringler, MS, ReadHealthy Communications’ founder & CEO. “But I knew that I had a unique perspective, a unique voice, and a unique experience that would bring something different to the industry, resonate with clients, and help them use communications to identify, solidify, and amplify their stories.”

Part of the unique perspective Jennifer refers to is her experience as a lifelong member of the blind and visually impaired community; she was born with rare vision disorder optic nerve hypoplasia.

“There’s something about living with a disability and being the only visually impaired person in almost every room you enter throughout your entire life that really teaches you how to communicate with – and listen to – others,” she says. “I believe my experience allows me to bring passion, empathy, and respect to the work I do for healthcare clients. There have been several times throughout my career that I was able to offer counsel based on my lived experience that helped guide a client on the best way to speak about their therapy, their brand, or their patients.”

Jennifer began her health communications career in 2010 as a reporter for Pharmaceutical Executive magazine, and later wrote features for Life Science Leader and other trade publications. Over the course of her career, she has served in writing and editorial capacities for nonprofits, industry trade publications, consumer health magazines, and more.

In 2013, Jennifer earned her Master of Science in Health Communication and transitioned from journalism to marketing, comms, and PR. She specializes in corporate communication, executive visibility and thought leadership, corporate and brand narratives, content development, media relations, and translating complex scientific information into compelling stories for healthcare providers, C-Suite, investors, payers, patients, and other stakeholders. She has worked in therapeutic areas including rare disease, oncology, cardiology, cell and gene therapy, ophthalmology, neurology, mental health, and more.

Jennifer has been published in Pharmaceutical Executive, Life Science Leader, Chief Healthcare Executive, PRNews, and many other industry blogs and publications. Her autobiographical essay about growing up visually impaired and later working at a summer camp for the blind and visually impaired was published in “Racism and Sexism: A Collaborative Study,” in 2004, by Kendall Hunt Publishing.

She holds a Bachelor of Arts in Writing from William Paterson University and a Master of Science in Health Communications from Boston University.

About ReadHealthy Communications, LLC

ReadHealthy Communications, LLC, is a public relations and corporate communications firm that helps healthcare and life sciences companies identify, solidify, and amplify their stories. With deep roots in scientific storytelling and healthcare journalism, we partner with pharmaceutical, biotech, and medical device companies; patient advocacy organizations and nonprofits; and entrepreneurs and startups in the healthcare space for corporate communications, marketing, media relations, and more. Whether you’re seeking to reach C-suite decision makers, legislators, healthcare providers, investors, payers, or patients, we make your health and life sciences stories matter to the stakeholders that matter to you. Because your stories matter. Your stories are changing the world. Discover more at http://www.readhealthy.net.

Contact:

Jennifer Ringler

973-647-5004

[email protected]

https://www.readhealthy.net/

SOURCE ReadHealthy Communications

Health

Cure HHT Becomes One Of The Few Patient Advocacy Organizations In The World To Sponsor A Clinical Trial Of A Self-Manufactured Investigational Drug Product

Leave a comment


HHT creates two types of vascular abnormalities, telangiectasias and/or arteriovenous malformations (AVMs), which are fragile and susceptible to rupture and bleeding, and untreated may result in lung and brain hemorrhage, stroke, heart failure and death. The most common symptom of HHT is frequent and severe nose bleeding, which is often dismissed as inconsequential, especially in children.

The launch of the Cure HHT-sponsored clinical trial of pazopanib (pa-zah-pa-nib) at several recruiting sites across the United States is the culmination of years of fundraising, advocacy and bold decision making by the organization after it lost access to the drug in 2015.

Pazopanib is an antiangiogenic therapeutic that is typically given orally to patients with cancerous tumors. When given off-label at a greatly reduced dose than the chemotherapeutic dose, pazopanib appears to show positive effects in HHT patients with outcomes like a reduced need for blood transfusion, iron infusion, and a decreased amount of nose bleeding.

Dr. Marie Faughnan, director of the HHT Center of Excellence at Toronto’s St. Michael’s Hospital, conducted a multi-center clinical trial in 2015 studying pazopanib to treat HHT-related bleeding at a dose of 50mg. All seven patients participating in the trial showed improvement. At the time, Glaxo-Smith-Kline (GSK) owned the drug product Votrient™ — which is the market name for their formulation of pazopanib. However, GSK sold the drug to Novartis shortly after the trial began and support of HHT-related clinical trials were halted. Thus, the study was closed, and Cure HHT and its physician partners lost access to the promising drug product to use in clinical research.

It was then that Cure HHT made the bold decision to raise the funds necessary to invest in purchasing and manufacturing the drug product to continue the trial on their own.

“Patients deserve approved therapeutics to help treat the chronic aspects of HHT, and they deserve it now,” said Marianne Clancy, Cure HHT’s Executive Director. “It was clear we had to take matters into our own hands if we wanted to make that happen. I am incredibly thankful to our donors who have helped make this groundbreaking effort possible, and to our staff who has worked tirelessly to help us finally reach this point.”

In 2020, Cure HHT successfully applied for and received a $5.2 million grant from the Department of Defense Peer Reviewed Medical Research Program and a $800,000 grant through the FDA to support the trial.

Cure HHT also fought to be granted an orphan drug designation and a breakthrough therapy designation for pazopanib in HHT from the FDA, both of which represented significant milestones in the organization’s pursuit to finally gain FDA approval for the first time for HHT.

“HHT is a not-so-uncommon multisystem inherited bleeding disorder with numerous morbid and potentially fatal complications. The fact that there are still no FDA-approved medications to treat this disease remains a major challenge for people with HHT,” said Dr. Hanny Al-Samkari, Associate Professor of Medicine at Harvard Medical School and co-director of the HHT Center of Excellence at the Massachusetts General Hospital. “Given its severity and complexity, we need an armamentarium of effective drugs to treat bleeding and other complications of this disease. The time is now to develop the treatments and cures of the future for this neglected disorder, which will make all the difference for the 70,000 Americans and 1.4 million people worldwide with HHT.”

Should the trial show positive results, Cure HHT will apply for a “New Drug Application” with the FDA, where the trial data and results will be evaluated, and hopefully the FDA will grant approval for pazopanib to treat HHT-related bleeding.

To learn more about the clinical trial, please visit CureHHT.org or ClinicalTrials.gov.

Follow us on Twitter, Instagram, LinkedIn and Facebook for more news and updates.

Media Contact

Riley Blevins, Cure HHT, 1 410-357-9932, [email protected], www.curehht.org

Twitter

SOURCE Cure HHT



Health

Envision Health Welcomes Stephanie Fraser to Bolster Strategic PR Efforts Amid Agency’s Continued Growth

Leave a comment


In an era of remarkable industry transformation, Envision Health remains dedicated to supporting the companies spearheading innovation and disrupting norms. Fraser’s arrival underscores the company’s unwavering commitment to staying at the forefront of this transformation, where novel therapies, digital advancements, and innovative approaches are revolutionizing the patient-provider experience and promoting more equitable, accessible, and cost-effective healthcare.

As Senior Director of PR, Stephanie will play a pivotal role in elevating the reputation of Envision Health’s clients, with a focus on amplifying credibility in the market and fostering engagement with a diverse range of stakeholders. Throughout her career, Fraser has steered executive communications and public relations for a spectrum of healthcare technology associations, software vendors, and marketing agencies. Notably, she spent over five years as a strategic communications advisor for CHIME (College of Healthcare Information Management Executives), and most recently, guided public relations and external communications efforts for Osso VR, an award-winning surgical training company.

“Stephanie’s wealth of industry experience, working with a range of key players, combined with her extraordinary knack for transforming brands into forward-thinking thought leaders, will be instrumental in supporting our clients,” said Kelley O. Smith, RN, MPH, chief clinical officer and co-founder of Envision Health.

“Stephanie possesses a profound understanding of both the evolving healthcare environment and the competitive PR landscape,” added Tim Busche, MBA, president, CEO, and co-founder of Envision Health. “Her strategic vision and expertise, along with her industry insider perspective, promises to be a driving force for our agency’s success.”

Individuals attending the annual HLTH conference in Las Vegas who are interested in connecting with Stephanie to discuss their PR needs, can email [email protected]. To discover what Envision Health’s award-winning team can do for you, visit envisionnmarketingpr.com.

About Envision Health
Envision Health is an award-winning marketing, public relations and consulting partner for HIT vendors, consulting firms, providers, payers, innovation hubs and a variety of other organizations supporting the public and private sectors. Founded by two industry experts with 50+ years of combined healthcare experience, we believe the convergence of clinical insight and marketing and PR expertise is the key to transforming healthcare communications. We are “clinically informed” — this means that everything we do is backed by deep healthcare expertise and first-hand knowledge of the landscape our customers operate in. Our services encompass everything from marketing strategies and tactics to company rebrands to media relations. Envision’s clinical and marketing experts ensure every marketing and public relations deliverable is strategically aligned, clinically informed and creatively inspired. For more information, visit http://www.envisionmarketingpr.com. 

Media Contact

Stephanie Fraser, Envision Health, 734-233-1483, [email protected], https://www.envisionmarketingpr.com/

SOURCE Envision Health

Health

MD Logic Health Unveils Revolutionary Natural Vitamin D3 + K2 Supplement

Leave a comment


“This formula is very exciting and represents MD Logic Health’s commitment to improvement. This pure blend has clinically meaningful levels of Natural Vitamin D3, along with both forms of vitamin K2 both M7 and MK4 without any harsh fillers or additives. This natural D3 provides the same form of vitamin D3 created by our bodies when exposed to sunlight. This similarity allows for optimal bioavailability and utilization in the body, potentially offering advantages over synthetic counterparts. This is a form of D3 and K2 that I feel confident to recommend to my patients, friends, and family. I am excited to see MD Logic Health continue to raise the bar on excellence in nutraceuticals.” – Dr. Roxanne Carfora, Board Certified Functional Medicine Physician.

Scott Emmens, a co-founder of MD Logic Health®, shared his excitement, noting, “This launch marks yet another milestone in our journey. Introducing a purely natural D3 coupled with both K2 forms is exhilarating. I eagerly anticipate watching MD Logic Health® spearhead scientific supplementation, especially with products that seamlessly complement each other to boost holistic health.”

MD Logic Health®’s vision is clear: enrich dietary supplementation to help individuals anchor their health journey. Merging the pristine natural D3 with both K2 forms and presenting it in an earth-loving glass bottle showcases their commitment to both wellness and planet sustainability.

The avant-garde Natural Vitamin D3 + K2 supplement by MD Logic Health® will hit the shelves on October 9. To stay in the loop regarding the launch and delve deeper into what MD Logic Health brings to the table, hop onto their official website at www.mdlogichealth.com.

About HealthNoise Magazine

HealthNoise is dedicated to providing you with the latest insights into health, wellness, nutrition, fitness, and self-care. We also provide our listeners with the best podcasters in the biohacking community. Join us on our journey to amplify wellness and live your healthiest, happiest life. Learn more about HealthNoise by visiting www.healthnoise.com.

Contact HealthNoise at [email protected]. 

Visit and follow us!

Facebook @mdlogichealth

Instagram @healthnoise

Twitter @mdlogichealth 

About MD Logic Health:

MD Logic Health® is committed to delivering sustainable, reliable, clean, and pure products that deliver maximum nutrition to our customers and protect our environment by reducing our carbon footprint. We believe everyone should have the opportunity to pursue their journey of health, and our promise is to provide the support you need to thrive and achieve optimal health and longevity. Our ever-expanding product line focuses on key areas such as brain health, beauty, and a healthy biome.

Our commitment remains firm: to provide you with the highest quality products, backed by cutting-edge research and an unwavering dedication to your well-being. Join us on this remarkable journey where passion fuels innovation, science drives progress, and nature guides our path. Together, we will achieve greatness and unlock the true potential of your health and vitality.

Our dedication to excellence has garnered national recognition, and we have been featured on CBS, ABC, NBC, and CW. Please visit us to learn more about our commitment to quality, passion for health and wellness, and access to education.

Visit and follow us!

Facebook @mdlogichealth

Instagram @mdlogichealth

Twitter @mdlogichealth

TikTok @mdlogichealth

LinkedIn

MD Logic Health® Contact:

Jyoti Hardat, VP Marketing

[email protected] | (877) 629-8711 x700

Media Contact

Jyoti Hardat, HealthNoise, 1 8776298711 700, [email protected], www.healthnoise.com 

Twitter, Facebook

SOURCE MD Logic Health



Health

Global Wellness Institute Announces Recipients of Second Annual “Susie Ellis Scholarship for Equity in Wellness”

Leave a comment


“Through their unwavering passion and dedication to the wellness industry, these scholarship recipients will no doubt make a profound impact and contribute positively to the global wellness community,” said Nancy Davis, GWI’s chief creative officer & executive director. “This scholarship lets us offer those who have perhaps dreamt of attending the Summit an opportunity to participate in conversations with global wellness leaders, exposing them to the topics and issues that are shaping the business of wellness now and into the future.”

The establishment of the scholarship fund was made possible by the generous contributions of Katrine and Bill Formby, Rick Stollmeyer, Lynne and Victor Brick, and the Szekely Family Foundation. Since its inception, the fund has experienced remarkable growth through the annual live auction held during the GWS gala event.

GWI relied heavily on input and guidance from two of its advisory board members, Hannah Messerli, PhD, and Nicola Finley, MD, to create a shortlist from the applicant pool. Subsequently, the GWS Board of Advisors voted, resulting in the four deserving recipients. This year’s recipients are:

  • Rita Prasad-Ildes, co-founder of Australia’s World Wellness Group, formed with the mission of addressing health inequities for migrants, refugees and people seeking asylum.
  • Johnathan Imperial, a senior advisor for the Queens Borough President’s Office. His role involves providing community wellness support to the largest public housing community in the United States.
  • Michelle Saudan, the founder of Dubai-based Amanzi Wellbeing. Her platform, dedicated to expanding awareness of Africa’s unique wellness assets, achieves this through wellness retreats.
  • Theodora WarriorHealy, an Indigenous empowerment facilitator based in Canada, whose ultimate goal is to offer wrap-around care for Indigenous healing.

The scholarship is named for Susie Ellis, GWS chair & CEO, who has been at the helm of the Summit and its sister non-profit organization, the GWI, since inception. Ellis expressed her excitement about the scholarship program’s growth, stating: “The doubling of scholarships awarded this year is a testament to the increased recognition of the importance of equity in wellness. We are delighted to support this exceptional group of individuals and provide them with a platform to contribute to the ongoing mission of making wellness accessible to all.”

If you would like to receive more information on this unique program and opportunity, please contact Jessi Brandt, manager of operations and logistics for the Global Wellness Institute at [email protected].

Registration for the 2023 Summit is now open. Apply here.

About the Global Wellness Institute: The Global Wellness Institute (GWI), a nonprofit 501(c)(3), is considered the leading global research and educational resource for the global wellness industry and is known for introducing major industry initiatives and regional events that bring together leaders to chart the future. GWI positively impacts global health and wellness by educating public institutions, businesses and individuals on how they can work to prevent disease, reduce stress and enhance the overall quality of life. Its mission is to empower wellness worldwide.

About the Global Wellness Summit: The Global Wellness Summit is an organization that brings together leaders and visionaries to positively shape the future of the $4.4 trillion global wellness economy. In addition to an annual conference, held at a different location around the globe, GWS also hosts regular virtual gatherings, including Wellness Master Classes and collaborative Wellness Sector Spotlights, and each year holds an in-person Wellness Real Estate & Communities Symposium. The organization’s annual Global Wellness Trends Report offers expert-based predictions on the future of wellness that are oft-quoted in the media. The 17th annual GWS will be held in Qatar, November 6-9, 2023.

Media Contact

Cassanda Cavanah, Cavanah Communications, 8183974630, [email protected], http://www.globalwellnessinstitute.com/ 

SOURCE Global Wellness Institute